Guardian Partners Inc. Astrazeneca PLC Transaction History
Guardian Partners Inc.
- $1.18 Trillion
- Q3 2025
A detailed history of Guardian Partners Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Guardian Partners Inc. holds 44,581 shares of AZN stock, worth $3.99 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
44,581
Previous 44,932
0.78%
Holding current value
$3.99 Million
Previous $3.18 Billion
18.19%
% of portfolio
0.32%
Previous 0.29%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...